Alnylam Pharmaceuticals, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -47.59M-43.57M-57.70M-106.01M-89.22M-400.60M-290.07M-490.87M-761.50M-886.12M-858.28M-852.82M-1131.16M-440.24M-278.16M
Depreciation and Depletion 4.80M5.00M4.60M6.10M5.00M6.70M9.60M11.90M12.80M16.60M30.20M36.80M39.10M51.60M55.10M
Share-based Compensation 27.52M19.40M16.68M12.36M20.70M33.06M45.78M75.53M92.82M157.75M174.84M139.87M165.72M230.65M221.68M272.08M
Deferred Taxes -7.20M10.74M-1.43M-0.71M-106.76M
Gains from Sales and Divestitures 0.14M0.11M0.50M0.16M
Gains from Investment Securities -5.84M-5.77M9.78M8.93M8.24M9.32M13.63M0.60M15.56M7.00M34.44M4.20M4.69M6.02M14.36M
Asset Writedowns and Impairment 0.59M
Non-cash Items 4.98M6.03M41.80M348.86M478.51M4.70M609.62M5.73M
Cash from Operations -100.64M-84.34M-87.07M-115.61M-68.66M-165.64M-189.14M-307.70M-382.79M-562.62M-278.43M-614.96M-641.69M-541.27M104.16M-8.31M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 37.19M39.66M42.13M41.08M42.98M
Depreciation & Amortization (CF) 8.36M4.94M5.12M9.04M10.23M11.93M19.05M15.13M11.90M15.25M17.18M34.77M47.57M44.47M54.05M56.67M
Change in Working Capital
Change in Receivables 1.86M-2.59M-1.98M-1.36M4.14M35.69M-31.64M15.04M10.67M-15.24M24.24M56.24M101.80M45.60M87.94M86.55M
Change in Inventory 22.64M32.41M35.43M26.41M34.14M-18.37M-13.59M
Change in Account Payables 9.90M-3.18M-3.51M-1.74M1.83M8.84M1.68M10.10M-4.94M15.48M
Change in Accured Expenses -0.48M0.65M2.46M-3.59M1.55M9.12M6.34M10.67M26.63M74.83M92.35M143.73M88.24M191.77M80.84M91.09M
Change in Taxes -0.47M10.67M-10.67M
Other Working Capital Changes -58.17M-60.70M-70.25M-8.56M-6.20M-7.79M6.82M14.62M20.71M35.07M392.25M-43.97M-50.40M-65.91M55.02M-235.45M
Investing Activities
Capital Expenditures 4.95M4.73M1.29M8.35M4.01M8.96M12.95M64.56M104.21M126.89M140.16M70.36M76.37M72.06M62.21M34.28M
Change in Intangibles 25.00M
Change in Acquisitions & Divestments 703.85M413.04M376.37M289.01M237.81M462.92M726.94M1116.46M597.30M1518.70M1775.40M1691.67M1463.55M2231.57M1553.80M1571.66M
Cash from Investing Activities 20.13M17.84M81.96M3.37M-130.50M-548.81M-321.32M142.59M-290.36M272.94M-417.68M-435.52M-273.30M169.35M-336.35M-116.84M
Financing Activities
Other financing activities -0.44M-0.22M0.12M10.10M1.99M15.39M0.38M0.31M0.71M8.40M19.60M31.00M24.67M
Cash from Financing Activities 4.89M3.66M0.74M93.41M200.93M736.47M616.18M177.83M1124.89M65.47M823.18M994.98M1247.12M425.75M172.13M294.16M
Additional items
Exchange Rate Effect -0.17M-0.03M-0.08M4.92M-9.02M-7.43M6.39M-15.24M
Change in Cash -75.78M-62.87M-4.37M-18.82M1.76M22.01M105.72M12.72M451.74M-224.20M127.00M-50.58M323.11M46.40M-53.67M153.77M
Free Cash Flow -105.59M-89.07M-88.36M-123.96M-72.66M-174.60M-202.09M-372.26M-487.00M-689.50M-418.58M-685.32M-718.07M-613.33M41.95M-42.59M
Net Cash Flow -75.61M-62.84M-4.37M-18.82M1.76M22.01M105.72M12.72M451.74M-224.20M127.08M-55.50M332.12M53.83M-60.06M169.01M